Clinical trial
Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14…
NCT00353184 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00353184 |
|---|---|
| Title | Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years |
| Official title | Randomized Controlled Trial of Oral Montelukast Added to Standard Therapy for Acute Asthma Exacerbations in Children Age 6 to 14 Years |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | American Academy of Pediatrics Ambulatory Pediatric Association |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Montelukast 5-mg orally added to standard therapy |
| Enrollment | 27 |
| Start date | Sep 1, 2001 |
| Primary completion | Oct 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Jul 18, 2006 |
| Last update posted | Feb 24, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: